177
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles

, , , , &
Pages 266-273 | Received 16 Apr 2012, Accepted 26 Jul 2012, Published online: 24 Sep 2012

References

  • Kelly HW, Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother 1992;26:81–91.
  • Nelson HS. Beta-adrenergic bronchodilators. N Engl J Med 1995;333:499–506.
  • Westerhof FJ, Zuidhof AB, Kok L, Meurs H, Zaagsma J. Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity. Eur Respir J 2005;25:864–872.
  • Corrigan DO, Healy AM, Corrigan OI. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur J Pharm Biopharm 2006;62:295–305.
  • Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech 2007;8:E107.
  • Huang WH, Yang ZJ, Wu H, Wong YF, Zhao ZZ, Liu L. Development of liposomal salbutamol sulfate dry powder inhaler formulation. Biol Pharm Bull 2010;33:512–517.
  • Paluch KJ, Tajber L, Elcoate CJ, Corrigan OI, Lawrence SE, Healy AM. Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt. J Pharm Sci 2011;100:3268–3283.
  • Narasimha Murthy S, Hiremath SR. Clinical pharmacokinetic and pharmacodynamic evaluation of transdermal drug delivery systems of salbutamol sulfate. Int J Pharm 2004;287:47–53.
  • British Pharmacopoeia. London: The Stationery Office, 2010, 3066–3075.
  • Learoyd TP, Burrows JL, French E, Seville PC. Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions. J Microencapsul 2010;27:162–170.
  • Sweetman SC. Martindale. London: Pharmaceutical Press, 2002, 770–772.
  • Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 1994;73:527–532.
  • Crescioli S, Dal Carobbo A, Maestrelli P, Boschetto P, Santagada T, Steinijans VW et al. Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. Ann Allergy Asthma Immunol 1996;77:106–110.
  • D’Alonzo GE, Crocetti JG, Smolensky MH. Circadian rhythms in the pharmacokinetics and clinical effects of beta-agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma. Chronobiol Int 1999;16:663–682.
  • Kips JC, Pauwels RA. Long-acting inhaled beta(2)-agonist therapy in asthma. Am J Respir Crit Care Med 2001;164:923–932.
  • Raghuvanshi RS, Tripathi KP, Jayaswal SB, Singh J. Release kinetics of salbutamol sulphate from wax coated microcapsules and tableted microcapsules. J Microencapsul 1992;9:449–455.
  • Hong Y, Hu FQ, Yuan H. Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles. Pharmazie 2006;61:312–315.
  • Jaspart S, Piel G, Delattre L, Evrard B. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv 2005;2:75–87.
  • Scalia S, Mezzena M. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. Drug Dev Ind Pharm 2009;35:192–198.
  • Albertini B, Mezzena M, Passerini N, Rodriguez L, Scalia S. Evaluation of spray congealing as technique for the preparation of highly loaded solid lipid microparticles containing the sunscreen agent, avobenzone. J Pharm Sci 2009;98:2759–2769.
  • Dalpiaz A, Mezzena M, Scatturin A, Scalia S. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine. Int J Pharm 2008;355:81–86.
  • Bodmeier R, Wang J, Bhagwatwar H. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs. J Microencapsul 1992;9:99–107.
  • Cook RO, Pannu RK, Kellaway IW. Novel sustained release microspheres for pulmonary drug delivery. J Control Release 2005;104:79–90.
  • Dalpiaz A, Cacciari B, Mezzena M, Strada M, Scalia S. Solid lipid microparticles for the stability enhancement of a dopamine prodrug. J Pharm Sci 2010;99:4730–4737.
  • Jaspart S, Bertholet P, Piel G, Dogné JM, Delattre L, Evrard B. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm 2007;65:47–56.
  • Passerini N, Perissutti B, Albertini B, Voinovich D, Moneghini M, Rodriguez L. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Release 2003;88:263–275.
  • McCarron PA, Donnelly RF, Al-Kassas R. Comparison of a novel spray congealing procedure with emulsion-based methods for the micro-encapsulation of water-soluble drugs in low melting point triglycerides. J Microencapsul 2008;25:365–378.
  • Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54 Suppl 1:S131–S155.
  • Sebti T, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 2006;63:51–58.
  • Adi S, Adi H, Tang P, Traini D, Chan HK, Young PM. Micro-particle corrugation, adhesion and inhalation aerosol efficiency. Eur J Pharm Sci 2008;35:12–18.
  • Bosquillon C, Lombry C, Preat V, Vanbever R. Comparison of particle sizing techniques in the case of inhalation dry powders. J Pharm Sci 2001;90:2032–2041.
  • Passerini N, Qi S, Albertini B, Grassi M, Rodriguez L, Craig DQ. Solid lipid microparticles produced by spray congealing: influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release. J Pharm Sci 2010;99:916–931.
  • Columbano A, Buckton G, Wikeley P. Characterisation of surface modified salbutamol sulphate-alkylpolyglycoside microparticles prepared by spray drying. Int J Pharm 2003;253:61–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.